切换导航
关闭
  • 菜单
  • Setting

Signaling Pathways - haspin kinase - HIPK3 - Catechol O-Methyltransferase (COMT) - Inward Rectifier Potassium (Kir) Channels

10 件产品

每页
清除全部
  1. LDN 209929 dihydrochloride
    B7785 LDN 209929 dihydrochloride
    Target: haspin kinase
    Summary: Haspin激酶抑制剂
      <40.58 mg/mL
      <40.58 mg/mL
  2. Nateglinide
    B2198 Nateglinide
    中文名: 那格列奈
    Target: Inward Rectifier Potassium (Kir) Channels
    Summary: 胰岛素促分泌剂
      ≥16.4 mg/mL
      insoluble in H2O
  3. Gliclazide
    B2195 Gliclazide
    中文名: 格列齐特
    Target: Inward Rectifier Potassium (Kir) Channels
    Summary: 钾通道抑制剂
      ≥15.6 mg/mL
      insoluble in H2O
  4. Mitiglinide Calcium
    B2193 Mitiglinide Calcium
    中文名: 米格列奈钙
    Target: Inward Rectifier Potassium (Kir) Channels
    Summary: 钾通道抑制剂
      ≥33.45 mg/mL
      insoluble in H2O
  5. Glibenclamide
    B1296 Glibenclamide
    中文名: 格列本脲
    Target: Inward Rectifier Potassium (Kir) Channels
    Summary: 胰岛素生产调节剂
      ≥49.4 mg/mL
      insoluble in H2O
  6. Terfenadine
    A8534 Terfenadine
    中文名: 特非那定
    Target: Voltage-gated Potassium (KV) Channels|Histamine H1 Receptors|Inward Rectifier Potassium (Kir) Channels
    Summary: 组胺H1受体拮抗剂
      ≥18 mg/mL
      insoluble in H2O
  7. DMAT
    A3368 DMAT
     2 Citation
    Target: Pim|CK2|HIPK2|HIPK3
    Summary: CK2抑制剂
      ≥23.85 mg/mL
      insoluble in H2O
  8. Tolcapone
    A4383 Tolcapone
    中文名: 托卡朋
    Target: Catechol O-Methyltransferase (COMT)
    Summary: COMT抑制剂
      ≥12 mg/mL
      insoluble in H2O
  9. Glimepiride
    A4033 Glimepiride
    中文名: 格列美脲
    Target: Inward Rectifier Potassium (Kir) Channels
    Summary: 磺酰脲类化合物
      ≥21.45 mg/mL
      insoluble in H2O
  10. Entacapone
    A4168 Entacapone
    中文名: 恩他卡朋
    Target: Catechol O-Methyltransferase (COMT)
    Summary: COMT抑制剂
      ≥13.1 mg/mL
      insoluble in H2O

10 件产品

每页